Board of Directors

Al B. Benson III, MD / Chair
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Thomas A. D'Amico, MD / Vice Chair
Duke Comprehensive Cancer Center

Nicolas C. Porter / Treasurer
H. Lee Moffitt Cancer Center and Research Institute

Marcy B. Waldinger, MHSA / Secretary
University of Michigan Comprehensive Cancer Center

Michael J. Anderegg
Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center

Clara D. Bloomfield, MD
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at
The Ohio State University

Carolyn C. Carpenter, MHA
Duke Comprehensive Cancer Center

Peter R. Carroll, MD
UCSF Helen Diller Family Comprehensive Cancer Center

Peter F. Coccia, MD
UNMC Eppley Cancer Center at The Nebraska Medical Center

Timothy Eberlein, MD
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Stephen B. Edge, MD
Roswell Park Cancer Institute

Paul F. Engstrom, MD, FACP
Fox Chase Cancer Center

David S. Ettinger, MD
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Robert A. Figlin, MD
City of Hope

David C. Hohn, MD
Roswell Park Cancer Institute

Mohammad Jahanzeb, MD
St. Jude Children's Research Hospital/University of Tennessee Cancer Institute

David H. Johnson, MD
Vanderbilt-Ingram Cancer Center

Adrienne C. Lang
The University of Texas M. D. Anderson Cancer Center

Terry Langbaum, MAS
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

R. Donald Leedy
Fox Chase Cancer Center

Ray Lynch
Huntsman Cancer Institute at the University of Utah

Maurie Markman, MD
The University of Texas M. D. Anderson Cancer Center

Susan S. Mills
Vanderbilt-Ingram Cancer Center

Joseph Mirro, MD
St. Jude Children`s Research Hospital/University of Tennessee Cancer Institute

Sean J. Mulvihill, MD
Huntsman Cancer Institute at the University of Utah

Joyce C. Niland, PhD
City of Hope

Sharon O`Keefe, MS
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine

Deena O'Shea, RN, MSN, OCN
Stanford Comprehensive Cancer Center

David G. Pfister, MD
Memorial Sloan-Kettering Cancer Center

Rita Potter
UNMC Eppley Cancer Center at The Nebraska Medical Center

S. Clifford Schold, Jr., MD
H. Lee Moffitt Cancer Center and Research Institute

Gerrie Shields
UCSF Helen Diller Family Comprehensive Cancer Center

Samuel M. Silver, MD, PhD
University of Michigan Comprehensive Cancer Center

Dennis J. Smith
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at
The Ohio State University

F. Marc Stewart, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

Myra Tanita
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance

William P. Vaughan, MD, MBA
University of Alabama at Birmingham Comprehensive Cancer Center

Timothy E. Volpe
Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Jane C. Weeks, MD, MSc
Dana-Farber/Brigham and Women’s Cancer Center | Massachusetts General Hospital Cancer Center

Management Team

William T. McGivney, Ph.D., is Chief Executive Officer of the National Comprehensive Cancer Network (NCCN). At the NCCN, Dr. McGivney is responsible for the development of NCCN strategies and programs aimed at improving the quality of cancer care available to patients in need. Such programs include the NCCN Clinical Practice Guidelines in Oncology™, the National Oncology Outcomes Database, the NCCN Specialty Oncology Network, the NCCN Oncology Research Program (ORP) and the NCCN Drugs & Biologics Compendium™. Strategically, Dr. McGivney is responsible for the growth of NCCN’s influence in the oncology community and for assuring the development of partnerships with managed care companies and employers, the development of NCCN’s health information capabilities and the expansion of centralized research programs.

Prior to joining NCCN in 1997, Dr. McGivney was the Director of the Division of Health Care Technology at the American Medical Association from 1982-1991. In 1991, Dr. McGivney joined Aetna Health Plans where he worked until 1997 as Vice President for Clinical and Coverage Policy. At Aetna, he directed several groups including technology assessment, clinical guidelines, national coverage policy, pharmacy policy, Institutes of Excellence Transplant Network, National Cardiac Care Network, national appeals, etc. In 1991, in collaboration with Grace Powers Monaco, he established the first formal independent outside review process. This process was used as the model for the passage of the Knowles-Friedman Act in California in 1996, the first of many states to mandate that health plans offer an outside review option.

Dr. McGivney, a recognized expert in coverage policy and in drug and device regulatory policy, was awarded the FDA Commissioner’s Medal of Appreciation in 1989. He has served on numerous national boards and committees including the UNOS Board of Directors, the Board of the Patient Advocate Foundation and the Medicare Coverage Advisory Committee. Presently, he serves as President of the Patient Advocate Foundation. He earned his undergraduate degree from Boston College, his Ph.D. at the University of North Carolina at Chapel Hill and completed a postdoctoral fellowship at Harvard Medical School.

Patricia J. Goldsmith is Executive Vice President/Chief Operating Officer at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Goldsmith is responsible for the overall operations of NCCN. She reports directly to the Chief Executive Officer and provides oversight of the Business Development and Marketing functions, the NCCN Oncology Research Program, the NCCN Oncology Outcomes Database program, the NCCN Guidelines and JNCCN functions, the Financial and Best Practices functions, the Public Affairs function, the Meeting Planning function, and the Enduring Materials function. In addition, she is responsible for national initiatives related to payors and employers and education related to these constituencies. Ms Goldsmith is also responsible for public policy initiatives at the Federal level.

Ms. Goldsmith formerly served as Vice President for Institutional Development, Public Affairs and Marketing at the H. Lee Moffitt Cancer Center & Research Institute in Tampa, Florida — an NCCN Member Institution. There she oversaw the Moffitt Cancer Center’s Foundation, Public Relations, Marketing, Business Development functions, and Fundraising initiatives. Before joining Moffitt, she developed and directed all managed care activities for the University of South Florida College of Medicine.

A frequent speaker at national meetings and symposia, Ms. Goldsmith was chosen by U. S. Representative Bill McCollum (R-Fl.) in 2003 to join a panel of 100 thought leaders representing every stakeholder interest in health care. This unique effort focused on building consensus about what structural changes could be made in our nation's health care delivery system to assure quality health care for future generations.

Ms. Goldsmith has studied at the Pennsylvania State University, the University of Missouri Bloch School of Business and the Harvard School of Public Health. She was a winner of the 1999 Distinguished Women in Business Award sponsored by the Business Journal of Tampa Bay and also was named the 1999 Leukemia Society Woman of the Year, an award based on her philanthropic efforts on behalf of the Leukemia Society.

Alana L. K. Brody, MBA, is Senior Vice President of Business Development and Marketing for the National Comprehensive Cancer Network (NCCN). In this role, Ms. Brody is key liaison with outside organizations in the development of programmatic partnerships and collaborations. In addition, she is responsible for the marketing, public relations and communication initiatives of the NCCN. Such areas and initiatives span the NCCN Clinical Practice Guidelines in Oncology™, the NCCN Drugs & Biologics Compendium™, the NCCN Guidelines Educational Conferences and Symposia and Industry Advisory Roundtables.

Prior to joining NCCN, Ms. Brody held a similar role for the National Spine Network, a “centers of excellence network” for orthopaedic and neurosurgeons. Her work in healthcare began as a Marketing Director with the Baystate Health System in Western Massachusetts. Ms. Brody earned her B.S. from Syracuse University and her M.B.A. from Rensselaer Polytechnic Institute.

Lisa G. Kimbro, CPA, MBA, is Senior Vice President, Finance/Chief Financial Officer for the National Comprehensive Cancer Network (NCCN). In this role, Ms. Kimbro manages NCCN’s financial and business initiatives as well as provides leadership to its NCCN Best Practices Committee.

Ms. Kimbro has extensive experience in both academic and community-based health care. She served as Director of Managed Care for the University of South Florida Physicians Group, where she was actively involved in the organization’s strategic planning initiatives and feasibility studies. In the community setting, she was the CFO of two dynamic and well-regarded physician groups in the Tampa Bay area. The responsibilities for those practices included (among others) business development, managed care contracting, financial reporting, patient accounting, compliance initiatives, and personnel management.

In addition to Ms. Kimbro’s healthcare experience, she has worked in public accounting, most recently with Ernst & Young Global as a senior manager in Quality and Risk Management in its Paris, France office.

Ms. Kimbro completed her master’s in Business Administration at the University of South Florida and her undergraduate degree at Florida State University. She is the co-author of the Governmental Accounting Standards Board Research Report, “The Needs of Users of Governmental Financial Reports.”

Joan S. McClure, MS, is Senior Vice President of Clinical Information and Publications for the National Comprehensive Cancer Network (NCCN). Ms. McClure is responsible for the NCCN Clinical Practice Guidelines in Oncology™, associated Guidelines for Patients in both English and Spanish, the NCCN Drugs & Biologics Compendium™, NCCN Information Technology, and JNCCN - The Journal of the National Comprehensive Cancer Network. Ms. McClure also serves as an Associate Editor for JNCCN. The NCCN Clinical Practice Guidelines in Oncology™ are a comprehensive set of guidelines detailing the sequential management decisions and interventions for the malignant cancers that affect 95% of all patients with cancer and for cancer prevention, screening, diagnosis and supportive care. Updated continuously, the NCCN Guidelines are recognized as the standard for clinical policy in the United States and have served as a model for guidelines programs elsewhere in the world.

Ms. McClure previously managed national oncology information programs for patients, health professionals and the public on contracts with the U. S. National Cancer Institute (NCI). She directed investigator and patient recruitment efforts in oncology for a multinational contract research organization where she also managed the technical and scientific effort to identify and develop standards for medical and toxicology data for submission to regulatory authorities in the United States, Europe, and Japan in a contract with the U.S. Food and Drug Administration (FDA). She supported NCI’s Cancer Therapy Evaluation Program in its 2000 revision of the Common Toxicity Criteria (CTC).

Eva M. Lepisto, MSc, MA, is Vice President of Technology Research and Development for the National Comprehensive Cancer Network (NCCN). Ms. Lepisto is responsible for evaluating and implementing new technology for NCCN. In this position, Ms. Lepisto directs the NCCN Oncology Outcomes Database Project operations, which is a network based data collection, reporting, and analytic system that describes the patterns and outcomes of care delivered and achieved in the management of patients with cancer. Ms. Lepisto also is responsible for the management and development of software for housing the NCCN Clinical Practice Guidelines in Oncology™.  

Ms. Lepisto previously was a Project Manager and Research Analyst for the Dana-Farber Cancer Institute and the National Comprehensive Cancer Network.  She also held research positions at Duke University Medical Center and Harvard School of Public Health.  She has also presented research at several professional society meetings.

Ms. Lepisto earned her BS in Immunology from the University of Toledo, MA in Medical Sociology from Duke University, and her MS in Epidemiology from Harvard School of Public Health.  

Diane E. Paul, MS, RN, is Vice President of the Oncology Research Program at the National Comprehensive Cancer Network (NCCN). In this role, Ms. Paul is responsible for developing and managing NCCN’s centralized, standardized infrastructure for the conduct of clinical trials among its 21 NCCN Member Institutions. The Oncology Research Program fosters collaboration among NCCN Member Institutions and pharmaceutical and biotechnology companies to bring promising and effective new treatments to patients with cancer.

Prior to working with NCCN, Ms. Paul served as Executive Director of the Cancer Institute of New Jersey Oncology Group, and Director of the Cancer Institute of New Jersey Network at the University of Medicine and Dentistry of New Jersey in New Brunswick, New Jersey. Ms. Paul speaks often on such topics as cancer screenings and prevention and has published articles in clinical publications including Cancer Investigation, Cancer Practice, and Oncology Nursing Forum.

For her work with the Cancer Hope Network, Ms. Paul received an “Unsung Heroine Award” in 1988 – an honor sponsored by the Women’s Network of New Jersey and presented by Senator Bill Bradley. She also received the Information Service Partnership Award from the National Cancer Institute in 1996. She is a recipient of Coping magazine’s Hero Award and Mirabella’s “1000 Points of Light” Award.

Ms. Paul completed her undergraduate degree in Nursing Science at the College of Saint Elizabeth in Convent Station, New Jersey, and her master’s degree in Psychiatric/Mental Health Nursing at Rutgers University. She is a member of the Association of Cancer Executives, the American Society of Clinical Oncology and the Oncology Nursing Society.

Alexander Yakovlev, MS, is Vice President of Information Technology for the National Comprehensive Cancer Network (NCCN). In this role, Mr. Yakovlev manages NCCN’s IT infrastructure including the NCCN website, intranet, and information systems that support the structure of the NCCN Clinical Practice Guidelines in Oncology™. 

Mr. Yakovlev was previously employed as WAN Manager for Computer Sciences Corporation in Moorestown, New Jersey. Before relocation to the United States, he also held similar management and administrative positions for corporations located in Russia and Germany.   

Mr. Yakovlev earned his MS in Electrical Engineering and Computer Science from St. Petersburg Technical University in Russia. He has also received extensive training and certifications in numerous operating and hardware systems that are currently used in medium- to large-sized corporations.